On completion of three years of operations, Global Regulatory & Consumer Insights (GRCIS) has opened it’s first overseas office in Ontario, Canada. The team is excited to face a new challenges and a new landscape.
Canada is widely regarded as the fourth most important destination for Clinical Research in world and as one of the most important country for clinical studies to support new drug registrations. “The increasing demand for regulatory services work in Canada drove the need for increased capacity,” said Mr. Tarun Pandotra
Tarun, GRCIS’s Founder & Director added. “We are now in better positioned to meet the continued needs of our customers in this region. Opening a Canada office for GRCIS is an exciting and significant milestone in the company’s evolution and is evidence that GRCIS acknowledges and embraces the full potential that the Canada can bring to the global business going forward”
About GRCIS
GRCIS is transforming regulatory services through our people, innovation and transparency. GRCIS provides personalized service customized to the unique requirements of each study. We support with our innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.
We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. At GRCIS, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the Regulatory landscape will continue to make a difference to healthcare patients around the world.
